Skip to main content
Premium Trial:

Request an Annual Quote

Clinical MicroArrays Closes $7.5 Million Series A Financing

NEW YORK, Oct. 21 (GenomeWeb News) - Clinical MicroArrays of Natick, Mass., on Thursday closed on a $7.5 million Series A financing led by Oxford Bioscience Partners.


Other investors include the Boston private equity firms of Rock Maple Ventures and Fletcher Spaght Venture Partners, as well as individual investors led by Jean "Coco" Montagu, chairman of the Clinical MicroArrays, and the founder of Genetic Microsystems, and later vice president of advanced technology at Affymetrix.


Clinical MicroArrays will use the funds to accelerate its development efforts with a goal of product commercialization in 2005, the company said in a statement.


The company is developing the MultiMark Express System, a technology platform consisting of protein surface chemistry for biochips, image detection, and sample processing for automating the analysis of disease-specific biomarker panels.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.